FDA’s second-in-command Abernethy leaving agency as Biden’s commissioner yet to be named
After just two years at the FDA, principal deputy chief Amy Abernethy is leaving the agency. As second-in-command and acting chief information officer, Abernethy oversaw tech and data modernization at the FDA and launched its COVID-19 accelerator project to boost real-world data gathering. Her unexpected departure comes as the search for a permanent FDA commissioner continues two… Read More »
